| 000 | 01643 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513103136.0 | ||
| 264 | 0 | _c19970512 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a0167-0115 | ||
| 024 | 7 |
_a10.1016/0167-0115(96)00039-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimonsson, E | |
| 245 | 0 | 0 |
_aInvolvement of phospholipase A2 and arachidonic acid in cholecystokinin-8-induced insulin secretion in rat islets. _h[electronic resource] |
| 260 |
_bRegulatory peptides _cSep 1996 |
||
| 300 |
_a101-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArachidonic Acid _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aEnzyme Inhibitors |
| 650 | 0 | 4 | _aFlavanones |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aInsulin _xmetabolism |
| 650 | 0 | 4 | _aInsulin Secretion |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 |
_aLipoxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhospholipases A _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPhospholipases A2 |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSalicylates _xpharmacology |
| 650 | 0 | 4 | _aSalicylic Acid |
| 650 | 0 | 4 |
_aSincalide _xpharmacology |
| 650 | 0 | 4 |
_aUmbelliferones _xpharmacology |
| 700 | 1 | _aKarlsson, S | |
| 700 | 1 | _aAhrén, B | |
| 773 | 0 |
_tRegulatory peptides _gvol. 65 _gno. 2 _gp. 101-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-0115(96)00039-0 _zAvailable from publisher's website |
| 999 |
_c8877650 _d8877650 |
||